Triptorelin

3 FDA-DMF suppliersProtein

Overview

Triptorelin is a protein active pharmaceutical ingredient (ChEMBL CHEMBL1201334).

Patent & exclusivity (US)

Per the FDA Orange Book (4 approved US products), the latest listed US patent on Triptorelin expires 29 Jun 2029. Generic API sourcing typically opens up once these lapse.

Chemical identity

Canonical SMILES
CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CNC=N7)NC(=O)[C@@H]8CCC(=O)N8
InChIKey
VXKHXGOKWPXYNA-PGBVPBMZSA-N

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.